Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
64.85
-2.70 (-4.00%)
At close: May 8, 2025, 4:00 PM
65.00
+0.15 (0.23%)
After-hours: May 8, 2025, 7:28 PM EDT
Novo Nordisk Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Novo Nordisk stock have an average target of 128, with a low estimate of 64 and a high estimate of 160. The average target predicts an increase of 97.38% from the current stock price of 64.85.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Novo Nordisk stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy → Hold Downgrades $105 → $64 | Buy → Hold | Downgrades | $105 → $64 | -1.31% | Apr 17, 2025 |
| UBS | UBS | Strong Sell → Strong Buy Upgrades n/a | Strong Sell → Strong Buy | Upgrades | n/a | n/a | Jan 8, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $156 → $105 | Buy | Maintains | $156 → $105 | +61.91% | Dec 23, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +146.72% | Nov 6, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $160 → $156 | Buy | Maintains | $160 → $156 | +140.56% | Oct 17, 2024 |
Financial Forecast
Revenue This Year
349.13B
from 290.40B
Increased by 20.22%
Revenue Next Year
405.32B
from 349.13B
Increased by 16.10%
EPS This Year
27.09
from 22.63
Increased by 19.72%
EPS Next Year
33.20
from 27.09
Increased by 22.55%
Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 379.1B | 497.5B | 563.1B | ||
| Avg | 349.1B | 405.3B | 449.0B | ||
| Low | 324.2B | 346.6B | 375.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 30.5% | 42.5% | 38.9% | ||
| Avg | 20.2% | 16.1% | 10.8% | ||
| Low | 11.6% | -0.7% | -7.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 32.01 | 40.78 | 46.86 | ||
| Avg | 27.09 | 33.20 | 37.37 | ||
| Low | 24.55 | 28.09 | 30.69 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 41.5% | 50.5% | 41.1% | ||
| Avg | 19.7% | 22.6% | 12.5% | ||
| Low | 8.5% | 3.7% | -7.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.